B-type natriuretic peptide measurement in heart failure

Daniel M. Spevack, Arthur Schwartzbard

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalClinical Cardiology
Volume27
Issue number9
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Brain Natriuretic Peptide
Heart Failure
Hormones
Serum
Myocardium

Keywords

  • B-type natriuretic peptide
  • Diagnosis
  • Heart failure
  • Natriuretic
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

B-type natriuretic peptide measurement in heart failure. / Spevack, Daniel M.; Schwartzbard, Arthur.

In: Clinical Cardiology, Vol. 27, No. 9, 09.2004, p. 489-494.

Research output: Contribution to journalArticle

Spevack, DM & Schwartzbard, A 2004, 'B-type natriuretic peptide measurement in heart failure', Clinical Cardiology, vol. 27, no. 9, pp. 489-494.
Spevack, Daniel M. ; Schwartzbard, Arthur. / B-type natriuretic peptide measurement in heart failure. In: Clinical Cardiology. 2004 ; Vol. 27, No. 9. pp. 489-494.
@article{117f5f7ca89549b1a1152b576fd5a2f7,
title = "B-type natriuretic peptide measurement in heart failure",
abstract = "Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.",
keywords = "B-type natriuretic peptide, Diagnosis, Heart failure, Natriuretic, Prognosis",
author = "Spevack, {Daniel M.} and Arthur Schwartzbard",
year = "2004",
month = "9",
language = "English (US)",
volume = "27",
pages = "489--494",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - B-type natriuretic peptide measurement in heart failure

AU - Spevack, Daniel M.

AU - Schwartzbard, Arthur

PY - 2004/9

Y1 - 2004/9

N2 - Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

AB - Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

KW - B-type natriuretic peptide

KW - Diagnosis

KW - Heart failure

KW - Natriuretic

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=4344646920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344646920&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 489

EP - 494

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 9

ER -